Skip to content

Neogen NEOG Impairment Charges

Impairment Charges at other companies

Zoetis logo
ZoetisZTS
$0-100%
Revvity logo
RevvityRVTY
$1.2M-79.0%
Agilent Technologies logo
Agilent TechnologiesA
$15M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$15.86M+50.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Spectrum Brands Holdings logo
Spectrum Brands HoldingsSPB

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's impairment charges?
Neogen (NEOG) reported impairment charges of $0 in Q4 2025.
How has Neogen's impairment charges changed year-over-year?
Neogen's impairment charges decreased by 100.0% year-over-year, from $2.08M to $0.
What does impairment charges mean?
Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.